Physician profile
Eric C Miller
NPI 1891702296
$31,722.53
in general payments reported to CMS, 2019-2025
33 companies · $687 in 2025
The $687 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,712 · 2020: $625 · 2021: $10K · 2022: $7,682 · 2023: $6,546 · 2024: $364 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,350 · Food and Beverage: $1,711 · Travel and Lodging: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,350.00 |
| Food and Beverage | $1,710.85 |
| Travel and Lodging | $1,536.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $11,718.23 | 2021-2023 | Toe Motion, X-Twist, Drawtight |
| Smith+Nephew, INC. | $7,624.28 | 2020-2025 | Evos, Bone Anchors With Arthroscopic Delivery System, Stravix |
| Stryker Corporation | $3,177.46 | 2019-2025 | Iconix, Variax, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $2,537.67 | 2021-2023 | |
| Arthrosurface Incorporated | $2,390.77 | 2019 | |
| Globus Medical, INC. | $1,482.69 | 2022-2023 | Clavicular Fracture Fixation |
| Orthofix Medical, INC. | $390.97 | 2019-2023 | Physio-Stim, Truelok System |
| Mimedx Group, INC. | $255.30 | 2024-2025 | |
| Depuy Synthes Sales INC. | $236.31 | 2019-2023 | Fibulink |
| Axogen | $163.90 | 2022-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Bone Support INC. | $150.14 | 2025 | Ceramentbone Void Filler, Cerament G |
| Trice Medical, INC. | $123.70 | 2021-2024 | |
| Paragon 28, INC. | $120.16 | 2019-2025 | Portfolio |
| Aroa Biosurgery Incorporated | $112.24 | 2023 | |
| Misonix INC | $105.42 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $98.89 | 2025 | Magellan |
| Celularity INC. | $96.00 | 2019 | |
| Ossio INC | $93.14 | 2022 | |
| Checkpoint Surgical, INC | $92.86 | 2020 | |
| Accufix Surgical INC. | $89.02 | 2022 | |
| Tenex Health INC. | $83.00 | 2019 | |
| Integra Lifesciences Corporation | $79.22 | 2019-2020 | |
| Horizon Therapeutics Plc | $75.19 | 2019 | |
| Bioventus LLC | $68.46 | 2022 | |
| Biocircuit Technologies INC | $61.56 | 2025 | Nerve Tape |
| Kerecis Limited | $55.50 | 2019 | |
| Sanara Medtech INC. | $55.44 | 2023 | Celleraterx |
| Rock Medical Orthopedics, INC. | $50.50 | 2021 | |
| Stability Biologics, LLC | $48.87 | 2021 | |
| Urgo Medical North America, LLC | $48.33 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Zimmer Biomet Holdings, INC. | $15.68 | 2019 | |
| Ethicon US, LLC | $15.50 | 2025 | Ethicon |
| Microaire Surgical Instruments LLC | $6.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.